Home › Rectal Cancer › Tennessee › Nashville

Pag-aaral pangklinika para sa Rectal Cancer sa Nashville, TN

9 pag-aaral para sa Rectal Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Nashville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

Sarah Cannon Research Institue, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Nagre-recruitPhase 1/2

Tennessee Oncology, PLLC, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07629960

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Nagre-recruitPhase 1/2

GSK Investigational Site, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07213609

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

Nagre-recruit

Vanderbilt University Medical Center, Nashville

Edad 22 hanggang 75 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07429110

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Nagre-recruitPhase 3

Vanderbilt University/Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT06205485

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06051695

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07011576

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Rectal Cancer sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.